sbt6050
Showing 1 - 1 of 1
HER2 Positive Solid Tumors Trial in Australia, Korea, Republic of, United States (SBT6050, pembrolizumab, Cemiplimab)
Active, not recruiting
- HER2 Positive Solid Tumors
- SBT6050
- +2 more
-
Boston, Massachusetts
- +11 more
Jun 27, 2022